In addition, AT1R antagonist also prevented gastric cancer progression by blocking the angiotensin II-induced overexpression of matrix metallopeptidase-2 (MMP-2) and MMP-9, critical components mediating tumor migration and invasion [93]. This evidence concerns the gene AGTR1 and neoplasm.